224 related articles for article (PubMed ID: 19202000)
21. Intrauterine and lactational exposure to fluoxetine enhances endothelial modulation of aortic contractile response in adult female rats.
Higashi CM; Sartoretto SM; Echem C; Lucchetti BFC; Carvalho MHC; Pelosi GG; Pinge-Filho P; Gerardin DCC; Moreira EG; Akamine EH; Ceravolo GS
Vascul Pharmacol; 2018 Sep; 108():67-73. PubMed ID: 29653281
[TBL] [Abstract][Full Text] [Related]
22. Involvement of COX-1 in A3 adenosine receptor-mediated contraction through endothelium in mice aorta.
Ansari HR; Nadeem A; Tilley SL; Mustafa SJ
Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3448-55. PubMed ID: 17921329
[TBL] [Abstract][Full Text] [Related]
23. An in vitro model of Fabry disease.
Shu L; Murphy HS; Cooling L; Shayman JA
J Am Soc Nephrol; 2005 Sep; 16(9):2636-45. PubMed ID: 16033856
[TBL] [Abstract][Full Text] [Related]
24. Effect of melatonin on vascular responses in aortic rings of aging rats.
Reyes-Toso CF; Obaya-Naredo D; Ricci CR; Planells FM; Pinto JE; Linares LM; Cardinali DP
Exp Gerontol; 2007 Apr; 42(4):337-42. PubMed ID: 17116384
[TBL] [Abstract][Full Text] [Related]
25. Caveolin-associated accumulation of globotriaosylceramide in the vascular endothelium of alpha-galactosidase A null mice.
Shu L; Shayman JA
J Biol Chem; 2007 Jul; 282(29):20960-7. PubMed ID: 17535804
[TBL] [Abstract][Full Text] [Related]
26. Serelaxin (recombinant human relaxin-2) prevents high glucose-induced endothelial dysfunction by ameliorating prostacyclin production in the mouse aorta.
Ng HH; Leo CH; Parry LJ
Pharmacol Res; 2016 May; 107():220-228. PubMed ID: 26993102
[TBL] [Abstract][Full Text] [Related]
27. Differentiation of cyclooxygenase 1- and 2-derived prostanoids in mouse kidney and aorta.
Qi Z; Cai H; Morrow JD; Breyer MD
Hypertension; 2006 Aug; 48(2):323-8. PubMed ID: 16801485
[TBL] [Abstract][Full Text] [Related]
28. Cyclooxygenase inhibition reduces blood pressure elevation and vascular reactivity dysfunction caused by inhibition of nitric oxide synthase in rats.
da Cunha V; Rossoni LV; Oliveira PA; Poton S; Pretti SC; Vassallo DV; Stefanon I
Clin Exp Hypertens; 2000 Feb; 22(2):203-15. PubMed ID: 10744360
[TBL] [Abstract][Full Text] [Related]
29. Role of cyclooxygenase-1 and -2 in endothelium-dependent contraction of atherosclerotic mouse abdominal aortas.
Li S; Liu B; Luo W; Zhang Y; Li H; Huang D; Zhou Y
Clin Exp Pharmacol Physiol; 2016 Jan; 43(1):67-74. PubMed ID: 26444418
[TBL] [Abstract][Full Text] [Related]
30. NS-398, a selective cyclooxygenase-2 blocker, acutely inhibits receptor-mediated contractions of rat aorta: role of endothelium.
Adeagbo AS; Patel D; Iddrissu A; Walker J; Thirumalai S; Joshua IG; Schuschke D; Wang Y
Eur J Pharmacol; 2003 Jan; 458(1-2):145-54. PubMed ID: 12498919
[TBL] [Abstract][Full Text] [Related]
31. Puerarin Inhibits Endothelium-Dependent Contractions in Mouse Carotid Arteries.
Chen M; Xiang L; Wu G; Liao Y; Cai Y
Med Sci Monit; 2020 Jun; 26():e923163. PubMed ID: 32555127
[TBL] [Abstract][Full Text] [Related]
32. Endothelial Cell Dysfunction and Hypoxia as Potential Mediators of Pain in Fabry Disease: A Human-Murine Translational Approach.
Klug K; Spitzel M; Hans C; Klein A; Schottmann NM; Erbacher C; Üçeyler N
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895103
[TBL] [Abstract][Full Text] [Related]
33. Long-term fenofibrate treatment impairs endothelium-dependent dilation to acetylcholine by altering the cyclooxygenase pathway.
Blanco-Rivero J; Márquez-Rodas I; Xavier FE; Aras-López R; Arroyo-Villa I; Ferrer M; Balfagón G
Cardiovasc Res; 2007 Jul; 75(2):398-407. PubMed ID: 17412316
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic strategy for Fabry disease by intravenous administration of adeno-associated virus 2 or 9 in α-galactosidase A-deficient mice.
Hayashi Y; Sehara Y; Watano R; Ohba K; Takayanagi Y; Muramatsu K; Sakiyama Y; Mizukami H
J Gene Med; 2023 Dec; 25(12):e3560. PubMed ID: 37392007
[TBL] [Abstract][Full Text] [Related]
35. α-Galactosidase A knockout mice: progressive organ pathology resembles the type 2 later-onset phenotype of Fabry disease.
Bangari DS; Ashe KM; Desnick RJ; Maloney C; Lydon J; Piepenhagen P; Budman E; Leonard JP; Cheng SH; Marshall J; Thurberg BL
Am J Pathol; 2015 Mar; 185(3):651-65. PubMed ID: 25553976
[TBL] [Abstract][Full Text] [Related]
36. Dissociation of globotriaosylceramide and impaired endothelial function in α-galactosidase-A deficient EA.hy926 cells.
Kaissarian N; Kang J; Shu L; Ferraz MJ; Aerts JM; Shayman JA
Mol Genet Metab; 2018 Dec; 125(4):338-344. PubMed ID: 30413389
[TBL] [Abstract][Full Text] [Related]
37. Cyclo-oxygenase-1 or -2-mediated metabolism of arachidonic acid in endothelium-dependent contraction of mouse arteries.
Zhou Y; Luo W; Zhang Y; Li H; Huang D; Liu B
Exp Physiol; 2013 Jul; 98(7):1225-34. PubMed ID: 23538462
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological characterization of the mechanisms underlying the vascular effects of succinate.
Leite LN; Gonzaga NA; Simplicio JA; do Vale GT; Carballido JM; Alves-Filho JC; Tirapelli CR
Eur J Pharmacol; 2016 Oct; 789():334-343. PubMed ID: 27475675
[TBL] [Abstract][Full Text] [Related]
39. Dietary L-arginine restores aspirin-induced endothelial dysfunction in rat aorta.
Bilgen I; Oner G; Eren E
Arch Physiol Biochem; 2003 Jul; 111(3):232-8. PubMed ID: 14972745
[TBL] [Abstract][Full Text] [Related]
40. Endothelial Dysfunction in Fabry Disease Is Related to Glycocalyx Degradation.
Pollmann S; Scharnetzki D; Manikowski D; Lenders M; Brand E
Front Immunol; 2021; 12():789142. PubMed ID: 34917096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
